InOut™ Overview

Why this Capsule

InOut stands alone as a non-invasive ingestible capsule  used  to sample localized gastrointestinal microbiota and content for medical diagnostics, treatment, research, and precision medicine.


Ingestible capsule, Size 000, Sampling microbiota, easy to swallow, home use

How it is used

The InOut immediate action or delayed action ingestible capsule is designed to be used at home or clinic. The patient consumes the capsule, recovers it from the stool, places it in the protective container, and sends or takes it to an attending lab, clinic, doctor, or researcher for analysis.

microbal sampling capsule intestinal content bodily fluids individualized medicine probiotics

The Difference

Endoscopic sampling methods require anesthesia, risk, recovery, and high costs in a clinic or hospital setting. Even then, the most remote areas of the small intestine cannot be reached. 


Fecal samples from stool are a complicated amalgamation of the total digestive processes and thwarts advances toward understanding the microbiome and its role in life, health, and disease.


 InOut non-invasive methods captures localized upstream microbiota and content from the chyme instead of feces and can be repeated at will with one or more capsules at a time.


InOut Capsules can be used to determine microbiota communities and bodily fluid content before and after diets, during and after medical treatments, and its simplicity makes it a boon to the DNA and microflora testing industry.


InOut is an unparalleled tool for medical diagnostics, treatment, research and individualized medicine. Consider immediate and differing delayed action capsules used alone or in series with one individual or any number of individuals repeatable at home or clinic. Obtain otherwise unavailable samples of microbe stains within their environment; sample virus mRNA before it degrades in the upper intestines. Shotgun metagenomics and high-throughput sequencing techniques  can finally be used on localized material.

InOut™ Capsule

Small intestine endoscope chyme feces flora microflora large intestine stomach colon ileum jejunum

The Idea

The idea for InOut was fostered by my wish to sample microbes and bodily fluid located in the small intestine and finding there was no practical way to do it. Present practice and methods are invasive and incomplete. No method exists for non-invasive localized gastrointestinal sampling. Incredibly  the medical, clinical, and research professions are limited to samples provided by mouth swabs, anal swabs or stool, and endoscopic procedures,

image102

Solving the Need


The need is verified by market reports,  research and medical publications, a Texas Tech University Technology Assessment Report, and National Science Foundation I-Corp market studies.

 



image103

Additional Information


Assembling the puzzle to achieve commercial production of the InOut capsule nears completion. Three of the 4 key key pieces are in place:


1. All US Patent Claims have been allowed, a CIP is pending, and the patent is on the International patent prosecution highway.


2. Proof of Concept  results charts, and  metagenomic sequencing Advanced Analysis Reports are available.


3.  USA companies have submitted costs and time frame bids to gain registration as a Class l or Class II medical device, micro mold and assemble the InOut capsules, and build a scalable custom robotic manufacturing facility. 



image104

4th Piece Invitation

investment biotech capsules class l FDA sterile capsules licensing patents funding due diligence

Let's package a deal to package the InOut™

We wish to enter into strategic relationships with our technology. 

 A confidentiality disclosure  agreement will be required before sharing full details. 

Contact Us

Send Message

InOut™ Biome

info@inoutbiome.com

Thank You